Metabolic dysfunction-associated steatotic liver disease and cardiovascular disease.
作者信息
Laeeq Tooba, Tun Kyaw Min
机构信息
Department of Internal Medicine, Kirk Kerkorian School of Medicine at the University of Nevada, Las Vegas, Nevada, USA.
出版信息
Clin Liver Dis (Hoboken). 2024 May 31;23(1):e0181. doi: 10.1097/CLD.0000000000000181. eCollection 2024 Jan-Jun.
Abstract
摘要
相似文献
1
Metabolic dysfunction-associated steatotic liver disease and cardiovascular disease.代谢功能障碍相关脂肪性肝病与心血管疾病
Clin Liver Dis (Hoboken). 2024 May 31;23(1):e0181. doi: 10.1097/CLD.0000000000000181. eCollection 2024 Jan-Jun.
2
Metabolic dysfunction-associated steatotic liver disease: Navigating terminological evolution, diagnostic frontiers and therapeutic horizon-an editorial exploration.代谢相关脂肪性肝病：术语演变、诊断前沿和治疗视野的探索——述评。
World J Gastroenterol. 2024 May 14;30(18):2387-2390. doi: 10.3748/wjg.v30.i18.2387.
3
From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus.从代谢功能障碍相关脂肪性肝病到代谢功能障碍相关脂肪性肝病：争议与共识
World J Hepatol. 2023 Dec 27;15(12):1253-1257. doi: 10.4254/wjh.v15.i12.1253.
4
Therapeutic management of metabolic dysfunction associated steatotic liver disease.代谢功能障碍相关脂肪性肝病的治疗管理。
United European Gastroenterol J. 2024 Mar;12(2):177-186. doi: 10.1002/ueg2.12525. Epub 2024 Jan 9.
5
Hyperinsulinemia, an overlooked clue and potential way forward in metabolic dysfunction-associated steatotic liver disease.高胰岛素血症，代谢功能障碍相关脂肪性肝病中一个被忽视的线索及潜在的前进方向。
Hepatology. 2023 Dec 5. doi: 10.1097/HEP.0000000000000710.
6
Cognitive dysfunction in early experimental metabolic dysfunction-associated steatotic liver disease is associated with systemic inflammation and neuroinflammation.早期实验性代谢功能障碍相关脂肪性肝病中的认知功能障碍与全身炎症和神经炎症有关。
JHEP Rep. 2023 Dec 21;6(3):100992. doi: 10.1016/j.jhepr.2023.100992. eCollection 2024 Mar.
7
Update in lean metabolic dysfunction-associated steatotic liver disease.瘦素代谢功能障碍相关脂肪性肝病的最新进展。
World J Hepatol. 2024 Mar 27;16(3):452-464. doi: 10.4254/wjh.v16.i3.452.
8
Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient and Physician Perspective.代谢功能障碍相关脂肪性肝病和代谢功能障碍相关脂肪性肝炎：患者及医生视角
J Clin Med. 2023 Sep 26;12(19):6216. doi: 10.3390/jcm12196216.
9
Cardiovascular outcomes post bariatric surgery in patients with metabolic dysfunction-associated steatotic liver disease - A systematic review and meta-analysis.代谢功能障碍相关脂肪性肝病患者减肥手术后的心血管结局——一项系统评价和荟萃分析
Clin Res Hepatol Gastroenterol. 2024 Jan;48(1):102261. doi: 10.1016/j.clinre.2023.102261. Epub 2023 Dec 7.
10
Validation of the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake: an analysis of data from a prospective cohort study.有过量饮酒史患者脂肪性肝病新命名法的验证：一项前瞻性队列研究数据分析
Lancet Gastroenterol Hepatol. 2024 Mar;9(3):218-228. doi: 10.1016/S2468-1253(23)00443-0. Epub 2024 Jan 11.
本文引用的文献
1
Management of cardiovascular risk in patients with metabolic dysfunction-associated steatotic liver disease.代谢功能障碍相关脂肪性肝病患者的心血管风险管理。
Eur J Intern Med. 2024 Apr;122:28-34. doi: 10.1016/j.ejim.2023.11.012. Epub 2023 Nov 25.
2
Association between diet soft drink consumption and metabolic dysfunction-associated steatotic liver disease: findings from the NHANES.饮食软饮料消费与代谢功能障碍相关脂肪性肝病的关系：NHANES 的研究结果。
BMC Public Health. 2023 Nov 20;23(1):2286. doi: 10.1186/s12889-023-17223-0.
3
The association between metabolic dysfunction-associated steatotic liver disease, cardiovascular and cerebrovascular diseases and the thickness of carotid plaque.代谢相关脂肪性肝病、心脑血管疾病与颈动脉斑块厚度的关系。
BMC Cardiovasc Disord. 2023 Nov 11;23(1):554. doi: 10.1186/s12872-023-03580-6.
4
Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease.代谢相关脂肪性肝病与心血管疾病风险。
Gut. 2024 Feb 23;73(3):533-540. doi: 10.1136/gutjnl-2023-331003.
5
Insulin resistance and central obesity determine hepatic steatosis and explain cardiovascular risk in steatotic liver disease.胰岛素抵抗和中心性肥胖决定肝脂肪变性，并解释脂肪性肝病患者的心血管风险。
Front Endocrinol (Lausanne). 2023 Sep 29;14:1244405. doi: 10.3389/fendo.2023.1244405. eCollection 2023.
6
Association between Alcohol Consumption and Metabolic Dysfunction-Associated Steatotic Liver Disease Based on Alcohol Flushing Response in Men: The Korea National Health and Nutrition Examination Survey 2019-2021.基于男性酒精性面红反应的饮酒与代谢相关脂肪性肝病的关系：2019-2021 年韩国国家健康和营养检查调查。
Nutrients. 2023 Sep 7;15(18):3901. doi: 10.3390/nu15183901.
7
Effects of social determinants of health on mortality and incident liver-related events and cardiovascular disease in steatotic liver disease.社会决定因素对脂肪性肝病患者死亡率及新发肝脏相关事件和心血管疾病的影响。
Aliment Pharmacol Ther. 2023 Sep;58(5):537-545. doi: 10.1111/apt.17631. Epub 2023 Jul 3.
8
Advances in the Diagnosis and Treatment of Non-Alcoholic Fatty Liver Disease.非酒精性脂肪性肝病的诊治进展。
Int J Mol Sci. 2023 Feb 2;24(3):2844. doi: 10.3390/ijms24032844.
9
Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association.非酒精性脂肪性肝病与心血管风险：美国心脏协会的科学声明
Arterioscler Thromb Vasc Biol. 2022 Jun;42(6):e168-e185. doi: 10.1161/ATV.0000000000000153. Epub 2022 Apr 14.
10
The Relationship between Insulin Resistance and Liver Damage in non-alcoholic Fatty Liver Patients.非酒精性脂肪肝患者胰岛素抵抗与肝损伤的关系
Sisli Etfal Hastan Tip Bul. 2020 Dec 11;54(4):411-415. doi: 10.14744/SEMB.2018.83604. eCollection 2020.
Zotero 插件